A study conducted at University of Pennsylvania’s Abramson Cancer Center has revealed possible drivers of recurrence in breast and ovarian tumors with BRCA1/BRCA2 mutations.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.